Montréal discovery could impact the study of chronic pain conditions
IRCM researchers uncover the critical role in pain processing of a gene associated with a rare disease
2015-04-22
(Press-News.org) Montréal, April 22, 2015 - Researchers at the IRCM led by Artur Kania, PhD, uncovered the critical role in pain processing of a gene associated with a rare disease. Their breakthrough, published in The Journal of Neuroscience, paves the way for a better understanding of chronic pain conditions.
Dr. Kania's team studies the way neural circuits transform harmful stimuli (such as cold, heat, and pinch) into the perception of pain. More precisely, they examined the gene Lmx1b and its involvement in pain processing. Mutations in this gene also cause a rare human disease called the Nail-patella syndrome (NPS), which is characterized by limb and kidney malformations. More importantly, NPS patients show reduced pain responses.
"By studying mouse models, we first showed this gene is essential for the survival of neurons and the development of the spinal cord," explains Dr. Kania, Director of the Neural Circuit Development research unit at the IRCM. "We then uncovered that removing the gene only in the spinal cord allows the mice to survive. However, it also results in reduced sensitivity to harmful mechanical (crushing, pinching) and thermal (heat, cold) stimulation."
"We also discovered the missing gene leads to missing neurons, which, in turn, affects the proper development and circuitry of the entire nervous system," says Nora Szabo, PhD, postdoctoral fellow in Dr. Kania's laboratory and first author of the study. "In fact, we observed a disruption in the connection between the spinal cord and specific brain centres, which prevents information from being transmitted correctly."
"Our team was the first to study this gene specifically in the spinal cord," adds Ronan V. da Silva, PhD student in the same laboratory and co-author of the article. "Our results demonstrate the critical role of Lmx1b for mechanical and thermal pain processing."
"Seeing as little is currently known about the pain pathways in the nervous system, this breakthrough will help advance our understanding of pain sensation," states Dr. Kania. "Our work also provides invaluable knowledge for the study of chronic pain and other pain conditions."
INFORMATION:
About the research project
The IRCM's research project was supported by the Quebec Pain Research Network, the Canadian Institutes of Health Research, the Canada Foundation for Innovation, Brain Canada and the W. Garfield Weston Foundation, as well as a McGill/Center for Neuroscience Zurich collaborative project grant and the IRCM's Angelo-Pizzagalli postdoctoral fellowship. The study was conducted in collaboration with Susana G. Sotocinal and Jeffrey S. Mogil from McGill University and Hanns Ulrich Zeilhofer from the University of Zurich.
For more information, please refer to the article summary published online by The Journal of Neuroscience: http://www.jneurosci.org/content/35/13/5233.short.
About Artur Kania
Artur Kania obtained his PhD in human and molecular genetics from Baylor College of Medicine in Texas, USA. He is Associate IRCM Research Professor and Director of the Neural Circuit Development research unit. Dr. Kania is Assistant Research Professor in the Department of Medicine (accreditation in molecular biology) at the Université de Montréal. He is also Adjunct Professor in the Department of Medicine (Division of Experimental Medicine), the Department of Biology, and the Department of Anatomy and Cell Biology at McGill University. In addition, he is a member of the Centre of Excellence in Neuroscience (CENUM) at the Université de Montréal, and a member of the Quebec Pain Research Network from the Fonds de la recherche du Québec - Santé. For more information, visit http://www.ircm.qc.ca/kania.
About the IRCM
The IRCM is a renowned biomedical research institute located in the heart of Montréal's university district. Founded in 1967, it is currently comprised of 35 research units and four specialized research clinics (cholesterol, cystic fibrosis, diabetes and obesity, hypertension). The IRCM is affiliated with the Université de Montréal, and the IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). It also maintains a long-standing association with McGill University. The IRCM is funded by the Quebec ministry of Economy, Innovation and Export Trade (Ministère de l'Économie, de l'Innovation et des Exportations).
ELSE PRESS RELEASES FROM THIS DATE:
2015-04-22
PHILADELPHIA - In the first major study to examine the use of a computer-assisted, photo-driven differential diagnosis generator for skin conditions, researchers at the Perelman School of Medicine at the University of Pennsylvania found physicians routinely used the tool, without an increase in calling for inpatient dermatology consultations. The software diagnostic tool, VisualDx, aids in diagnosing dermatologic conditions by allowing physicians to enter information such as the type and location of a rash, and associated symptoms such as pain or itching, and then generating ...
2015-04-22
SAN FRANCISCO--It may seem unlikely that a large earthquake would take place hundreds of kilometers away from a tectonic plate boundary, in areas with low levels of strain on the crust from tectonic motion. But major earthquakes such as the Mw 7.9 2008 Chengdu quake in China and New Zealand's 2011 Mw 6.3 quake have shown that large earthquakes do occur and can cause significant infrastructure damage and loss of life. So what should seismologists look for if they want to identify where an earthquake might happen despite the absence of historical seismic activity?
Roger ...
2015-04-22
COLUMBUS, Ohio - Researchers have uncovered the first evidence of a genetic link between prodigy and autism.
The scientists found that child prodigies in their sample share some of the same genetic variations with people who have autism.
These shared genetic markers occur on chromosome 1, according to the researchers from The Ohio State University and Nationwide Children's Hospital in Columbus.
The findings confirm a hypothesis made by Joanne Ruthsatz, co-author of the study and assistant professor of psychology at Ohio State's Mansfield campus.
In a previous study, ...
2015-04-22
WASHINGTON - Vehicle cost, current battery technology, and inadequate consumer knowledge are some of the barriers preventing widespread adoption of plug-in electric vehicles, says a new congressionally mandated report from the National Research Council. Developing less expensive, better performing batteries is essential to reducing overall vehicle cost, and a market strategy is needed to create awareness and overcome customer uncertainty. The report recommends a range of incentives that the federal government can offer to address these and other barriers.
The report ...
2015-04-22
The brain is a privileged organ in the body. So vital to life, the brain is protected from alterations elsewhere in the body by a highly regulated gateway known as the blood-brain barrier, which allows only selected molecules to pass through.
In certain diseases, however, such as multiple sclerosis, the barrier can be improperly breached. These "leaks" can allow immune cells and inflammatory molecules to pass through, causing inflammation that leads to neuronal damage.
In a new study, researchers have made insights into how the blood-brain barrier, or BBB, is maintained, ...
2015-04-22
The widespread use of cloth masks by healthcare workers may actually put them at increased risk of respiratory illness and viral infections and their global use should be discouraged, according to a UNSW study.
The results of the first randomised clinical trial (RCT) to study the efficacy of cloth masks were published today in the journal BMJ Open.
The trial saw 1607 hospital healthcare workers across 14 hospitals in the Vietnamese capital, Hanoi, split into three groups: those wearing medical masks, those wearing cloth masks and a control group based on usual practice, ...
2015-04-22
(Boston)-- Individuals with mild Traumatic Brain Injury (mTBI), particularly those who have had loss of consciousness (LOC), show structural brain abnormalities in their white matter as measured by Diffusion Tensor Imaging (DTI).
These findings, which appear in the journal NeuroImage: Clinical, is the only study to date to demonstrate that mTBI with LOC is associated with brain abnormalities that lead to decreased performance in verbal memory.
Blast-related TBI has been a common injury among returning troops due to the widespread use of improvised explosive devices ...
2015-04-22
WASHINGTON (April 22, 2015) -- New research published this week in Nature has found several drugs could lead to new treatment options for multiple sclerosis (MS), including two drugs that effectively treat MS at the source, in vivo. When administered at the peak of disease, these two drugs showed a striking reversal of disease severity.
At the pathological level, MS is a disease in which the immune system attacks the protective myelin sheath, a type of insulation that covers nerves, ultimately disrupting communication between the brain and the body and leading to nerve ...
2015-04-22
April 22, 2014 (SILVER SPRING, Md.) - Ebola survivors experienced negative health effects that persisted more than two years after the 2007-2008 Bundibugyo ebolavirus (BDBV) outbreak in Uganda that claimed 39 lives. These findings are detailed in a paper published online today in Lancet ID. This represents the largest long-term study to-date on Ebola survivors, and examines health events more than two years after initial exposure to BDBV.
"Defining EVD-related health consequences could help improve patient care for survivors," said Dr. Hannah Kibuuka, the principal ...
2015-04-22
As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to increase. Patients who develop this disease usually start experiencing symptoms around age 60 or older. Currently, there's no cure, but scientists are reporting a novel approach that reversed Parkinson's-like symptoms in rats. Their results, published in the journal ACS Nano, could one day lead to a new therapy for human patients.
Rajnish Kumar Chaturvedi, Kavita Seth, Kailash Chand Gupta and colleagues from the CSIR-Indian Institute of Toxicology Research note that among other ...
LAST 30 PRESS RELEASES:
[Press-News.org] Montréal discovery could impact the study of chronic pain conditions
IRCM researchers uncover the critical role in pain processing of a gene associated with a rare disease
